PHH
Income statement / Annual
Last year (2024), Park Ha Biological Technology Co., Ltd.'s total revenue was $2.38 M,
a decrease of 3.13% from the previous year.
In 2024, Park Ha Biological Technology Co., Ltd.'s net income was $478.56 K.
See Park Ha Biological Technology Co., Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
10/31/2024 |
10/31/2023 |
10/31/2022 |
10/31/2021 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$2.38 M |
$2.46 M |
$1.92 M |
$931.04 K |
$456.00 M |
$622.00 M |
$790.00 M |
$639.00 M |
$2.84 B |
$2.74 B |
| Cost of Revenue |
$195.34 K
|
$310.99 K
|
$509.16 K
|
$311.16 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$2.19 M
|
$2.15 M
|
$1.41 M
|
$619.87 K
|
$456.00 M
|
$622.00 M
|
$790.00 M
|
$639.00 M
|
$2.84 B
|
$2.74 B
|
| Gross Profit Ratio |
0.92
|
0.87
|
0.73
|
0.67
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$36.71 K
|
$30.88 K
|
$60.67 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$814.86 K
|
$484.96 K
|
$707.49 K
|
$751.82 K
|
$294.00 M
|
$409.00 M
|
$323.00 M
|
$358.00 M
|
$681.00 M
|
$595.00 M
|
| Selling & Marketing Expenses |
$361.33 K
|
$299.62 K
|
$438.60 K
|
$369.03 K
|
$44.00 M
|
$64.00 M
|
$79.00 M
|
$78.00 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.18 M
|
$784.57 K
|
$1.15 M
|
$1.12 M
|
$338.00 M
|
$473.00 M
|
$402.00 M
|
$436.00 M
|
$681.00 M
|
$595.00 M
|
| Other Expenses |
$179.90 K
|
$152.11 K
|
$6.44 K
|
$0.00
|
-$1.09 B
|
-$1.41 B
|
-$1.42 B
|
-$1.09 B
|
-$3.31 B
|
-$3.31 B
|
| Operating Expenses |
$1.39 M
|
$967.56 K
|
$1.21 M
|
$1.12 M
|
-$752.00 M
|
-$935.00 M
|
-$1.02 B
|
-$657.00 M
|
-$2.63 B
|
-$2.72 B
|
| Cost And Expenses |
$1.59 M
|
$1.28 M
|
$1.72 M
|
$1.43 M
|
-$752.00 M
|
-$935.00 M
|
-$1.02 B
|
-$657.00 M
|
-$2.63 B
|
-$2.72 B
|
| Interest Income |
$783.00
|
$1.59 K
|
$263.00
|
$167.00
|
-$36.00 M
|
$43.00 M
|
$44.00 M
|
$42.00 M
|
$1.46 B
|
$1.46 B
|
| Interest Expense |
$0.00
|
$0.00
|
$194.00
|
$1.19 K
|
$73.00 M
|
$75.00 M
|
$90.00 M
|
$130.00 M
|
$185.00 M
|
$212.00 M
|
| Depreciation & Amortization |
$22.69 K
|
$20.06 K
|
$30.49 K
|
$39.01 K
|
$14.00 M
|
$16.00 M
|
$18.00 M
|
$23.00 M
|
$1.24 B
|
$1.24 B
|
| EBITDA |
$816.40 K |
$1.20 M |
$220.70 K |
-$445.00 K |
-$282.00 M |
-$297.00 M |
-$209.00 M |
$5.00 M |
$1.46 B |
$1.27 B |
| EBITDA Ratio |
0.34
|
0.49
|
0.11
|
-0.48
|
-0.62
|
-0.48
|
-0.26
|
0.01
|
0.51
|
0.46
|
| Operating Income Ratio |
0.33
|
0.48
|
0.1
|
-0.54
|
-0.65
|
-0.5
|
-0.29
|
-0.03
|
0.07
|
0.01
|
| Total Other Income/Expenses Net |
-$293.00
|
$1.02 K
|
-$7.01 K
|
$16.02 K
|
$23.00 M
|
$9.00 M
|
-$2.02 B
|
-$1.58 B
|
$29.00 M
|
$59.00 M
|
| Income Before Tax |
$793.42 K
|
$1.18 M
|
$190.01 K
|
-$485.00 K
|
-$273.00 M
|
-$304.00 M
|
-$213.00 M
|
-$284.00 M
|
$241.00 M
|
$87.00 M
|
| Income Before Tax Ratio |
0.33
|
0.48
|
0.1
|
-0.52
|
-0.6
|
-0.49
|
-0.27
|
-0.44
|
0.08
|
0.03
|
| Income Tax Expense |
$314.86 K
|
$329.53 K
|
-$1.29 K
|
$0.00
|
-$79.00 M
|
-$111.00 M
|
-$82.00 M
|
-$99.00 M
|
$77.00 M
|
-$6.00 M
|
| Net Income |
$478.56 K
|
$852.04 K
|
$191.30 K
|
-$485.00 K
|
-$194.00 M
|
-$193.00 M
|
-$131.00 M
|
-$185.00 M
|
$135.00 M
|
$34.00 M
|
| Net Income Ratio |
0.2
|
0.35
|
0.1
|
-0.52
|
-0.43
|
-0.31
|
-0.17
|
-0.29
|
0.05
|
0.01
|
| EPS |
0.0183 |
0.0325 |
0.0073 |
-0.0185 |
-4.14 |
-3.6 |
-2.37 |
-3.36 |
2.36 |
0.6 |
| EPS Diluted |
0.0183 |
0.0325 |
0.0073 |
-0.0185 |
-4.14 |
-3.6 |
-2.37 |
-3.36 |
2.06 |
0.56 |
| Weighted Average Shares Out |
$26.20 M
|
$26.20 M
|
$26.20 M
|
$26.20 M
|
$46.91 M
|
$53.63 M
|
$55.20 M
|
$55.00 M
|
$57.36 M
|
$56.82 M
|
| Weighted Average Shares Out Diluted |
$26.20 M
|
$26.20 M
|
$26.20 M
|
$26.20 M
|
$46.91 M
|
$53.63 M
|
$55.20 M
|
$55.00 M
|
$65.86 M
|
$61.60 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
